Onderneming Alexandria Co. For Pharmaceuticals & Chemical Industries
Aandelen
AXPH
EGS38341C011
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
215,1 EGP | 0,00% | 0,00% | +20,65% |
Vakgebied
Verkoop per activiteit
EGP in miljoen | 2019 | Gewicht | 2020 | Gewicht | Delta |
---|---|---|---|---|---|
Finished Goods
99,0
%
| 821 | 99,0 % | 1 014 | 99,0 % | +23,52% |
Other Operating Income
1,0
%
| 8 | 1,0 % | 10 | 1,0 % | +23,86% |
Verkoop per regio
EGP in miljoen | 2019 | Gewicht | 2020 | Gewicht | Delta |
---|---|---|---|---|---|
Egypt
100,0
%
| 829 | 100,0 % | 1 024 | 100,0 % | +23,52% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | - | - | |
Ahmed Fuad
ADM | Chief Administrative Officer | - | - |
Director/Board Member | - | - | |
Magdy Fathallah
PRN | Corporate Officer/Principal | - | - |
Sales & Marketing | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | - | - | |
Director/Board Member | - | - | |
Chief Executive Officer | - | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 5 000 000 | 981 182 ( 19,62 %) | 0 | 19,62 % |
Bedrijfsgegevens
Alexandria Pharmaceuticals
Gamila Bohreid Road Awayed
21938, Alexandria
+
Sector
Verkoop per activiteit
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,65% | 23,05 mln. | |
+37,22% | 723 mld. | |
+31,07% | 598 mld. | |
-3,08% | 364 mld. | |
+20,24% | 331 mld. | |
+4,02% | 288 mld. | |
+15,98% | 244 mld. | |
+9,78% | 210 mld. | |
-5,24% | 208 mld. | |
+8,76% | 169 mld. |
- Beurs
- Aandelen
- Koers AXPH
- Onderneming Alexandria Co. For Pharmaceuticals & Chemical Industries